Calpain-1 is required for hydrogen peroxide-induced myotube atrophy

American Journal of Physiology - Cell Physiology

Volumn 296, Issue 2, 2009, Pages

  McClung, J M ^a   Judge, A R ^a   Talbert, E E ^a   Powers, S K ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Oxidative stress; Protease; Skeletal muscle

Indexed keywords

ALPHA ACTININ; CALPAIN 1; CALPAIN 2; CASPASE 3; CYSTEINE PROTEINASE; DESMIN; FODRIN; HYDROGEN PEROXIDE; LEUPEPTIN; MYOSIN; SMALL INTERFERING RNA; TALIN; TROPONIN I;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL STRESS; CONTROLLED STUDY; ENZYME SUBSTRATE; EXPOSURE; MOUSE; MUSCLE ATROPHY; MYOTUBE ATROPHY; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SKELETAL MUSCLE; TRANSIENT TRANSFECTION;

ANIMALS; CALPAIN; CASPASE 3; CELL LINE; CELL SURVIVAL; CYSTEINE PROTEINASE INHIBITORS; HYDROGEN PEROXIDE; LEUPEPTINS; MICE; MUSCLE PROTEINS; MUSCULAR ATROPHY; MYOBLASTS, SKELETAL; OXIDATIVE STRESS; RNA INTERFERENCE; SARCOMERES; SUPEROXIDE DISMUTASE; TIME FACTORS; TRANSFECTION;

EID: 60849139422     PISSN: 03636143     EISSN: 15221563     Source Type: Journal    
DOI: 10.1152/ajpcell.00497.2008     Document Type: Article

References (40)

1. Braga M, Sinha Hikim AP, Datta S, Ferrini MG, Brown D, Ko- vacheva EL, Gonzalez-Cadavid NF, Sinha-Hikim I. Involvement of oxidative stress and caspase 2-mediated intrinsic pathway signaling in age-related increase in muscle cell apoptosis in mice. Apoptosis 13: 822-832, 2008.
2. Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, Pignol B, Hasselgren PO. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/ MAFbx and MuRFl expression. Am J Physiol Regul Integr Comp Physiol 290:R1589-R1597, 2006.
3. Forrester MT, Stamler JS. A classification scheme for redox-based modifications of proteins. Am J Respir Cell Mol Biol 36: 135-137, 2007.
4. Goll DE, Neti G, Mares SW, Thompson VF. Myofibrillar protein turnover: the proteasome and the calpains. J Anim Sci 86, Suppl 14: E19-E35, 2008.
5. Goll DE, Thompson VF, Li H, Wei W, Cong J. The calpain system. Physiol Rev 83: 731-801, 2003.
6. Higaki Y, Mikami T, Fujii N, Hirshman MF, Koyama K, Seino T, Tanaka K, Goodyear LJ. Oxidative stress stimulates skeletal muscle glucose uptake through a phosphatidylinositol 3-kinase-dependent pathway. Am J Physiol Endocrinol Metab 294: E889-E897, 2008.
7. Huang J, Forsberg NE. Role of calpain in skeletal-muscle protein degradation. Proc Natl Acad Sci USA 95:12100-12105, 1998.
8. Janssen-Heininger YM, Mossman BT, Heintz NH, Forman HJ, Kaly anaraman B, Finkel T, Stamler JS, Rhee SG, van der Vliet A. Redox-based regulation of signal transduction: principles, pitfalls, and promises. Free Radic Biol Med 45: 1-17, 2008.
9. Kandarian SC, Jackman RW. Intracellular signaling during skeletal muscle atrophy. Muscle Nerve 33: 155-165, 2006.
10. Kemp M, Go YM, Jones DP. Nonequilibrium thermodynamics of thiol/ disulfide redox systems: a perspective on redox systems biology. Free Radic Biol Med 44: 921-937, 2008.
11. Kramerova I, Kudryashova E, Venkatraman G, Spencer MJ. Calpain 3 participates in sarcomere remodeling by acting upstream of the ubiq- uitin-proteasome pathway. Hum Mol Genet 16: 1006, 2007.
12. Laviano A, Meguid MM, Preziosa I, Fanelli FR. Oxidative stress and wasting in cancer. Curr Opin Clin Nutr Metab Care 10: 449 -456, 2007.
13. Li X, Moody MR, Engel D, Walker S, Clubb FJ Jr, Sivasubramanian N, Mann DL, Reid MB. Cardiac-specific overexpression of tumor necrosis factor-alpha causes oxidative stress and contractile dysfunction in mouse diaphragm. Circulation 102: 1690-1696, 2000.
14. Li YP, Chen Y, John J, Moylan J, Jin B, Mann DL, Reid MB. TNF-alpha acts via p38 MAPK to stimulate expression of the ubiquitin ligase atrogin1/MAFbx in skeletal muscle. FASEB J 19: 362-370, 2005.
15. Li YP, Chen Y, Li AS, Reid MB. Hydrogen peroxide stimulates ubiq- uitin-conjugating activity and expression of genes for specific E2 and E3 proteins in skeletal muscle myotubes. Am J Physiol Cell Physiol 285: C806-C812, 2003.
16. Maes K, Testelmans D, Powers S, Decramer M, Gayan-Ramirez G. Leupeptin inhibits ventilator-induced diaphragm dysfunction in rats. Am J Respir Crit Care Med 175: 1134-1138, 2007.
17. Mammucari C, Milan G, Romanello V, Masiero E, Rudolf R, Del Piccolo P, Burden SJ, Di Lisi R, Sandri C, Zhao J, Goldberg AL, Schiaffino S, Sandri M. FoxO3 controls autophagy in skeletal muscle in vivo. Cell Metab 6: 458-471, 2007.
18. Mastrocola R, Reffo P, Penna F, Tomasinelli CE, Boccuzzi G, Baccino FM, Aragno M, Costelli P. Muscle wasting in diabetic and in tumor- bearing rats: role of oxidative stress. Free Radic Biol Med 44: 584-593, 2008.
19. McClung JM, Kavazis AN, Deruisseau KC, Falk DJ, Deering MA, Lee Y, Sugiura T, Powers SK. Caspase-3 regulation of diaphragm myo- nuclear domain during mechanical ventilation-induced atrophy. Am J Respir Crit Care Med 175: 150-159, 2007.
20. McClung JM, Kavazis AN, Whidden MA, DeRuisseau KC, Falk DJ, Criswell DS, Powers SK. Antioxidant administration attenuates mechanical ventilation-induced rat diaphragm muscle atrophy independent of protein kinase B (PKB Akt) signalling. J Physiol 585: 203-215, 2007.
21. McClung JM, Whidden MA, Kavazis AN, Falk DJ, Deruisseau KC, Powers SK. Redox regulation of diaphragm proteolysis during mechanical ventilation. Am J Physiol Regul Integr Comp Physiol 294: R1608-R1617, 2008.
22. Menconi M, Gonnella P, Petkova V, Lecker S, Hasselgren PO. Dexa-methasone and corticosterone induce similar, but not identical, muscle wasting responses in cultured L6 and C2C12 myotubes. J Cell Biochem 105:353-364, 2008.
23. Minnaard R, Schrauwen P, Schaart G, Hesselink MK. UCP3 in muscle wasting, a role in modulating lipotoxicity? FEBS Lett 580: 5172-5176, 2006.
24. Otis JS, Ashikhmin YI, Brown LA, Guidot DM. Effect of HIV-1-related protein expression on cardiac and skeletal muscles from transgenic rats. AIDS Res Ther 5: 8, 2008.
25. Otis JS, Brown LA, Guidot DM. Oxidant-induced atrogin-1 and transforming growth factor-beta1 precede alcohol-related myopathy in rats. Muscle Nerve 36: 842-848, 2007.
26. Powers SK, Kavazis AN, DeRuisseau KC. Mechanisms of disuse muscle atrophy: role of oxidative stress. Am J Physiol Regul Integr Comp Physiol 288: R337-R344, 2005.
27. Powers SK, Kavazis AN, McClung JM. Oxidative stress and disuse muscle atrophy. J Appl Physiol 102: 2389-2397, 2007.
28. Prochniewicz E, Lowe DA, Spakowicz DJ, Higgins L, O'Conor K, Thompson LV, Ferrington DA, Thomas DD. Functional, structural, and chemical changes in myosin associated with hydrogen peroxide treatment of skeletal muscle fibers. Am J Physiol Cell Physiol 294: C613-C626, 2008.
29. Purintrapiban J, Wang MC, Forsberg NE. Degradation of sarcomeric and cytoskeletal proteins in cultured skeletal muscle cells. Comp Biochem Physiol B Biochem Mol Biol 136: 393-401, 2003.
30. Sandri M, Sandri C, Gilbert A, Skurk C, Calabria E, Picard A, Walsh K, Schiaffino S, Lecker SH, Goldberg AL. Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy. Cell 117: 399-412, 2004.
31. Senf SM, Dodd SL, McClung JM, Judge AR. Hsp70 overexpression inhibits NF-kappaB and Foxo3a transcriptional activities and prevents skeletal muscle atrophy. FASEB J 22: 3836-3845, 2008.
32. Servais S, Letexier D, Favier R, Duchamp C, Desplanches D. Prevention of unloading-induced atrophy by vitamin E supplementation: links between oxidative stress and soleus muscle proteolysis? Free Radic Biol Med 42: 627-635, 2007.
33. Siems W, Capuozzo E, Lucano A, Salerno C, Crifo C. High sensitivity of plasma membrane ion transport ATPases from human neutrophils towards 4-hydroxy-2,3-trans-nonenal. Life Sci 73: 2583-2590, 2003.
34. Smith IJ, Lecker SH, Hasselgren PO. Calpain activity and muscle wasting in sepsis. Am J Physiol Endocrinol Metab 295: E762-E771, 2008.
35. Sompol P, Ittarat W, Tangpong J, Chen Y, Doubinskaia I, Batinic- Haberle I, Abdul HM, Butterfield DA, St Clair DK. A neuronal model of Alzheimer's disease: an insight into the mechanisms of oxidative stress-mediated mitochondrial injury. Neuroscience 153: 120-130, 2008.
36. Steffens BW, Batia LM, Baarson CJ, Choi CK, Grow WA. The pesticide methoxychlor decreases myotube formation in cell culture by slowing myoblast proliferation. Toxicol In Vitro 21: 770-781, 2007.
37. Stitt TN, Drujan D, Clarke BA, Panaro F, Timofeyva Y, Kline WO, Gonzalez M, Yancopoulos GD, Glass DJ. The IGF-1/PI3K/Akt pathway prevents expression of muscle atrophy-induced ubiquitin ligases by inhibiting FOXO transcription factors. Mol Cell 14: 395-403, 2004.
38. Tidball JG, Spencer MJ. Expression of a calpastatin transgene slows muscle wasting and obviates changes in myosin isoform expression during murine muscle disuse. J Physiol 545: 819 -828, 2002.
39. Wing SS. Control of ubiquitination in skeletal muscle wasting. Int J Bio-chem Cell Biol 37: 2075-2087, 2005.
40. Zhao J, Brault JJ, Schild A, Cao P, Sandri M, Schiaffino S, Lecker SH, Goldberg AL. FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells. Cell Metab 6: 472-483, 2007.